Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 218 entries
View as:

Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds

Phase: N/A Priority: Normal
NCT ID: NCT00704262 Org: User:
Start: 05/31/08 End: 12/31/09 Due: 12/31/10

Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00216892 Org: User:
Start: 04/30/05 End: 12/31/05 Due: 12/31/06

Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively

Phase: N/A Priority: Normal
NCT ID: NCT02305888 Org: User:
Start: 03/31/15 End: 08/31/15 Due: 08/31/16

Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT01820260 Org: User:
Start: 04/30/13 End: 08/31/14 Due: 08/31/15

Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp

Phase: N/A Priority: Normal
NCT ID: NCT02406014 Org: User:
Start: 04/30/15 End: 06/30/16 Due: 06/30/17

Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin

Phase: N/A Priority: Normal
NCT ID: NCT03673527 Org: User:
Start: 11/22/18 End: 02/11/19 Due: 02/11/20

A Study Evaluating the Safety of LEO 90105 and Its Vehicle, After Multiple Administration on Intact Skin of Healthy Japanese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01293383 Org: User:
Start: 03/31/11 End: 03/31/11 Due: 03/31/12

A Study to Investigate Efficacy and Safety With LEO 90100 Compared With Daivobet® Ointment in Adult Chinese Subjects With Stable Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT05919082 Org: User:
Start: 06/21/23 End: 03/05/24 Due: 03/05/25

A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas

Phase: N/A Priority: Normal
NCT ID: NCT01007591 Org: User:
Start: 10/31/09 End: 12/31/10 Due: 12/31/11

Dermatopharmacokinetic Trial of LEO 80185 Gel

Phase: N/A Priority: Normal
NCT ID: NCT02605057 Org: User:
Start: 11/30/15 End: 07/31/16 Due: 07/31/17

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7

Phase: N/A Priority: Normal
NCT ID: NCT03761537 Org: User:
Start: 12/13/18 End: 09/28/20 Due: 09/28/21

An International, Multi-centre, Prospective, Non-controlled, Open, Single-group, 8-week Trial in Adolescent Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02038569 Org: User:
Start: 01/31/14 End: 02/13/18 Due: 02/13/19

Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

Phase: N/A Priority: Normal
NCT ID: NCT01600014 Org: User:
Start: 05/31/12 End: 02/28/14 Due: 02/28/15

LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00833872 Org: User:
Start: 01/31/09 End: 11/30/09 Due: 11/30/10

LEO19123 Cream in the Treatment of Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00392067 Org: User:
Start: 10/31/06 End: 06/30/07 Due: 06/30/08

A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01105286 Org: User:
Start: 04/30/10 End: 06/30/10 Due: 06/30/11

Cromoglicate in Mastocytosis

Phase: N/A Priority: Normal
NCT ID: NCT01701843 Org: User:
Start: 10/31/12 End: 02/28/13 Due: 02/28/14

A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities

Phase: N/A Priority: Normal
NCT ID: NCT01787383 Org: User:
Start: 02/28/13 End: 01/31/14 Due: 01/31/15

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

Phase: N/A Priority: Normal
NCT ID: NCT03683719 Org: User:
Start: 11/28/18 End: 04/20/20 Due: 04/20/21

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT00277394 Org: User:
Start: 12/31/05 End: 07/31/08 Due: 07/31/09

An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

Phase: N/A Priority: Normal
NCT ID: NCT02496546 Org: User:
Start: 07/31/15 End: 03/31/16 Due: 03/31/17

Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02695940 Org: User:
Start: 03/31/16 End: 09/30/16 Due: 09/30/17

Effect of LEO 90100 on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis VulgarisExtensive Psoriasis Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01600222 Org: User:
Start: 05/31/12 End: 05/31/13 Due: 05/31/14

Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema

Phase: N/A Priority: Normal
NCT ID: NCT05355818 Org: User:
Start: 07/14/22 End: 12/17/24 Due: 12/17/25

The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847

Phase: N/A Priority: Normal
NCT ID: NCT01141179 Org: User:
Start: 05/31/10 End: 02/28/11 Due: 02/28/12